FAT2 and breast carcinoma: Immunohistochemical analysis of 31 paired clinical specimens was performed to corroborate the <i>in vitro</i> findings.<h4>Results</h4>FAT2 mRNA was significantly downregulated in breast cancer tissues and was associated with advanced clinical stage, higher T stage, and negative hormone receptor status.